GCM
Gladius Capital Management’s Collegium Pharmaceutical COLL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-830
| Closed | -$32.1K | – | 68 |
|
|
2024
Q3 | $32.1K | Sell |
830
-162
| -16% | -$6.26K | ﹤0.01% | 168 |
|
|
2024
Q2 | $31.9K | Buy |
+992
| New | +$31.9K | ﹤0.01% | 179 |
|
|
2024
Q1 | – | Sell |
-1,370
| Closed | -$42.2K | – | 271 |
|
|
2023
Q4 | $42.2K | Buy |
1,370
+69
| +5% | +$2.12K | 0.01% | 120 |
|
|
2023
Q3 | $29.1K | Buy |
1,301
+234
| +22% | +$5.23K | ﹤0.01% | 214 |
|
|
2023
Q2 | $22.9K | Sell |
1,067
-168
| -14% | -$3.61K | ﹤0.01% | 206 |
|
|
2023
Q1 | $29.6K | Sell |
1,235
-478
| -28% | -$11.5K | ﹤0.01% | 205 |
|
|
2022
Q4 | $39.7K | Sell |
1,713
-358
| -17% | -$8.31K | ﹤0.01% | 174 |
|
|
2022
Q3 | $34K | Buy |
+2,071
| New | +$34K | ﹤0.01% | 208 |
|